Genmab — Oktober 2019
-
Genmab chooses Ibex to take gene candidates to IND in 12 months https://www.manufacturingchemist.com/news/article_page/Genmab_chooses_Ibex_to_take_gene_candidates_to_IND_in_12_months/159041 https://www.lonza.com/about-lonza/media-center/news/Tensid/2019-10-14-15-35-English.aspx
-
-
Anti-CD38 CAR NK-cells: an off-the shelf therapy for multiple myeloma
-
Enig Bella..og godnat herfra.
-
God morgen.
-
-
Hvorfor kan du ikke finde den? Den er på drop-down listen.
-
Janssen and Nanolek Announce Localization of Darzalex in Russia https://gmpnews.net/2019/10/82891/
-
After PRAC , now on the CHMP agenda this week “Extension of indication to extend the existing therapeutic indication for Darzalex
(daratumumab) in combination with lenalidomide and dexamethasone (Rd) AND in combination with bortezomib, thalidomide and dexamethasone -
12:45 iirc
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind